鼻咽癌
医学
诱导化疗
实体瘤疗效评价标准
内科学
对数秩检验
化疗
肿瘤科
放射科
核医学
生存分析
进行性疾病
放射治疗
作者
Chao Luo,Wenjie Huang,Shuqi Li,Haojiang Li,Guangying Ruan,Gui Fu,Lizhi Liu
出处
期刊:Head & neck
[Wiley]
日期:2024-03-28
卷期号:46 (10): 2540-2549
摘要
Abstract Background We aimed to establish the most suitable threshold for objective response (OR) in the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 in patients with nasopharyngeal carcinoma (NPC). Methods According to RECIST 1.1, we retrospectively evaluated MR images of NPC lesions in patients before and after induction chemotherapy (IC). Restricted cubic spline and maximally selected rank statistics were used to determine the cut‐off value. Survival rates and differences between groups were compared with Kaplan–Meier curves and log‐rank tests. Results Of 1126 patients, 365 cases who received IC treatment were suitable for RECIST 1.1 evaluation. The 20% cut‐off value maximized between‐group differences according to maximally selected rank statistics. No difference in distant metastasis‐free survival between OR and non‐response groups was shown using the primary threshold of OR (30%), while it differed when 20% was employed. Conclusions With an optimal cut‐off value of 20%, RECIST may assist clinicians to accurately evaluate disease response in NPC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI